# OnCo record tumor-lysis-syndrome (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/tumor-lysis-syndrome/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "tumor-lysis-syndrome" ;
  schema:name "Tumour lysis syndrome (TLS)"@en ;
  schema:description "When a treatment kills cancer cells faster than the body can clear their contents, flooding the blood with potassium, phosphate and uric acid and injuring the kidneys and heart. Risk is highest in bulky CLL and high-count AML, which is why venetoclax starts at a tiny dose and ramps up over weeks."@en ;
  schema:url <https://onco.cc/terms/tumor-lysis-syndrome/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Tumor_lysis_syndrome> ;
  owl:sameAs <http://www.wikidata.org/entity/Q998803> ;
  schema:citation <https://en.wikipedia.org/wiki/Tumor_lysis_syndrome>, <https://doi.org/10.1111/bjh.13403> ;
  onco:cancers <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/sonrotoclax/> .